You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

August 14, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Rivaroxaban linked with lower inpatient costs compared to warfarin among NVAF patients

Hospitalization costs for rivaroxaban (Xarelto, Janssen) were significantly lower than warfarin in patients with nonvalvular atrial fibrillation (NVAF), according to a study. » Can rivaroxaban reduce the cost of a hospital stay?

WHO OKs experimental drug use in Ebola outbreak

The World Health Organization (WHO) has given the green light to the use of experimental drugs in the Ebola outbreak in West Africa. The death toll has reached 1,000. » Find out more about Ebola drugs

EDITOR'S PICK

Study: Hep C drugs could increase Medicare Part D spending in 2015

The federal government's cost for Medicare Part D will increase between $2.9 billion and $5.8 billion if we see 15% to 30% of hepatitis C (HCV)-infected beneficiaries receive treatment in 2015 and the cost of treatment averages $84,000, according to a new study. » Full article

Continuing Education

MTM essentials for atrial fibrillation and drug-induced arrhythmia management

This month's article is the seventh in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review current clinical practice guidelines related to atrial fibrillation.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exam and earn up to 2 CPE credits, click here to log in with the session code 14DT09-ZXT88.


Announcement: Starting this month, our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

 

Related Articles

Rivaroxaban alternative option for elderly

GSK clinical trial may start this fall for Ebola vaccine

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group